Hasil Pencarian - Lisa Zimmer

Perbaiki Hasil
  1. 1
    Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case Report

    Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A... oleh Johanna Matull, Elisabeth Livingstone, Axel Wetter, Lisa Zimmer, Anne Zaremba, Harald Lahner, Dirk Schadendorf, Selma Ugurel

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Impact of the Histidine-Containing Phosphocarrier Protein HPr on Carbon Metabolism and Virulence in <i>Staphylococcus aureus</i>

    Impact of the Histidine-Containing Phosphocarrier Protein HPr on Carbon Metabolism and Virulence in <i>Staphylococcus aureus</i> oleh Linda Pätzold, Anne-Christine Brausch, Evelyn-Laura Bielefeld, Lisa Zimmer, Greg A. Somerville, Markus Bischoff, Rosmarie Gaupp

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab

    Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab oleh Oskar Krueger, Robin Eisenburger, Alpaslan Tasdogan, Lisa Zimmer, Elisabeth Livingstone, Eva Hadaschik, Sarah Theurer, Berthold Brodin, Dirk Schadendorf, Selma Ugurel

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.

    TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. oleh Klaus G Griewank, Rajmohan Murali, Bastian Schilling, Tobias Schimming, Inga Möller, Iris Moll, Marion Schwamborn, Antje Sucker, Lisa Zimmer, Dirk Schadendorf, Uwe Hillen

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management

    Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management oleh Jan Leipe, Lucie Heinzerling, Thomas K Eigentler, Michael Fluck, Jessica C Hassel, Daniela Heller-Schenck, Matthias Pauschinger, Arndt Vogel, Lisa Zimmer, Ralf Gutzmer

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy

    Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy oleh Saskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, Elisabeth Livingstone, Benjamin Stolte, Andreas Thimm, Kathrin Kizina, Selma Ugurel, Christoph Kleinschnitz, Martin Glas, Lisa Zimmer, Tim Hagenacker

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Corticosteroids augment BRAF inhibitor vemurafenib induced lymphopenia and risk of infection.

    Corticosteroids augment BRAF inhibitor vemurafenib induced lymphopenia and risk of infection. oleh Wiebke Sondermann, Klaus G Griewank, Bastian Schilling, Elisabeth Livingstone, Julia C Leyh, Natalia Rompoti, Ioana Cosgarea, Tobias Schimming, Dirk Schadendorf, Lisa Zimmer, Uwe Hillen

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy

    Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy oleh Julia Pohl, Matthias Totzeck, Raluca‐I. Mincu, Simone M. Margraf, Lena Scheipers, Lars Michel, Amir A. Mahabadi, Lisa Zimmer, Tienush Rassaf, Ulrike B. Hendgen‐Cotta

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?

    Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors? oleh Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, Saskia Bolz, Selma Sirin, Martin Glas, Jürgen C. Becker, Selma Ugurel, Alexander Roesch, Dirk Schadendorf, Elisabeth Livingstone, Tim Hagenacker, Lisa Zimmer

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

    Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma oleh Justin Ferdinandus, Anne Zaremba, Lisa Zimmer, Lale Umutlu, Robert Seifert, Francesco Barbato, Selma Ugurel, Eleftheria Chorti, Viktor Grünwald, Ken Herrmann, Dirk Schadendorf, Wolfgang Peter Fendler, Elisabeth Livingstone

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report

    Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report oleh Ann-Kathrin Stoppek, Sied Kebir, Andreas Junker, Kathy Keyvani, Stefan Zülow, Lazaros Lazaridis, Teresa Schmidt, Daniela Pierscianek, Martin Stuschke, Ulrich Sure, Christoph Kleinschnitz, Björn Scheffler, Lisa Zimmer, Martin Glas

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition – Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry

    Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition – Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspa... oleh Jan-Malte Placke, Josefine Rawitzer, Henning Reis, Jassin Rashidi-Alavijeh, Elisabeth Livingstone, Selma Ugurel, Eva Hadaschik, Klaus Griewank, Kurt Werner Schmid, Dirk Schadendorf, Dirk Schadendorf, Alexander Roesch, Alexander Roesch, Lisa Zimmer

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

    Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG oleh Dirk Schadendorf, Lisa Zimmer, Bastian Schilling, Selma Ugurel, Valerie Glutsch, Anja Gesierich, Matthias Goebeler, Jürgen C Becker, Sebastian Haferkamp, Christian Posch, Michael Weichenthal, Ulrike Leiter, Christoffer Gebhardt, Patrick Schummer, Hermann Kneitz, Detlef Klein

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Prognostic factors in the primary care of patients with Merkel cell carcinoma: A monocentric cohort study of 108 patients from a tertiary referral centre

    Prognostic factors in the primary care of patients with Merkel cell carcinoma: A monocentric cohort study of 108 patients from a tertiary referral centre oleh Jan‐Malte Placke, Maximilian Zahn, Hannah Zillikens, Frederik Krefting, Georg C. Lodde, Lisa Zimmer, Elisabeth Livingstone, Eva Hadaschik, Antje Sucker, Alexander Roesch, Alpaslan Tasdogan, Nalini K. Srinivas, Dirk Schadendorf, Jürgen C. Becker, Selma Ugurel

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.

    Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma. oleh Lisa Zimmer, Julia Vaubel, Peter Mohr, Axel Hauschild, Jochen Utikal, Jan Simon, Claus Garbe, Rudolf Herbst, Alexander Enk, Eckhart Kämpgen, Elisabeth Livingstone, Leonie Bluhm, Rainer Rompel, Klaus G Griewank, Michael Fluck, Bastian Schilling, Dirk Schadendorf

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates

    COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates oleh Georg C. Lodde, Melanie Fiedler, Ulf Dittmer, Jan-Malte Placke, Philipp Jansen, Jürgen C. Becker, Jürgen C. Becker, Jürgen C. Becker, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Dirk Schadendorf, Wiebke Sondermann, Selma Ugurel, Selma Ugurel

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype

    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype oleh Lea Jessica Albrecht, Anna Höwner, Klaus Griewank, Smiths S. Lueong, Nils vonNeuhoff, Peter A. Horn, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Selma Ugurel, Lisa Zimmer, Susanne Horn, Jens T. Siveke, Dirk Schadendorf, Renáta Váraljai, Alexander Roesch

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma

    Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma oleh Lisa Zimmer, Serigne Lo, Celeste Lebbe, Olivier Michielin, Ines Pires da Silva, Paolo Antonio Ascierto, Matteo Carlino, Alexander Menzies, Douglas B Johnson, Claudia Trojanello, Georgina Long, Tasnia Ahmed, Clara Allayous, Johanna Mangana, Florentia Dimitriou, Danny Zakria, Camille Gerard

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition

    The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition oleh Luca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, Jan Viehof, Ágnes Enyedi, Ágnes Bilecz, Balázs Győrffy, Marcell Baranyi, Anna-Mária Tőkés, Jeovanis Gil, György Marko-Varga, Klaus G. Griewank, Lisa Zimmer, Renáta Váraljai, Antje Sucker, Anne Zaremba, Dirk Schadendorf, Clemens Aigner, Balázs Hegedüs

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab

    The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab oleh Domenico Mallardo, Rachel Woodford, Alexander M. Menzies, Lisa Zimmer, Andrew williamson, Egle Ramelyte, Florentia Dimitriou, Alexandre Wicky, Roslyn Wallace, Mario Mallardo, Alessio Cortellini, Alfredo Budillon, Victoria Atkinson, Shahneen Sandhu, Michielin Olivier, Reinhard Dummer, Paul Lorigan, Dirk Schadendorf, Georgina V. Long, Ester Simeone, Paolo A. Ascierto

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: